发明名称 QUINAZOLONE DERIVATIVE AND NF-kappaB ACTIVATION INHIBITOR
摘要 PROBLEM TO BE SOLVED: To provide a quinazolone derivative having an NF-κB activation-inhibiting activity, and to provide a medicine which contains the derivative as an active ingredient and can be used as a medicine for treating autoimmune diseases, inflammatory diseases, viral diseases and cancers. SOLUTION: This NF-κB activation inhibitor contains a quinazolone derivative represented by the general formula (I) [R<SP>1</SP>is OR<SP>2</SP>(R<SP>2</SP>is a substituted or un-substituted 1 to 6C alkyl, a substituted or un-substituted 2 to 6C alkenyl, a substituted or un-substituted 2 to 6C alkynyl, a substituted or un-substituted aryl, a substituted or un-substituted aralkyl, or a substituted or un-substituted heteroarylalkyl), a substituted or un-substituted aryl, or a substituted or un-substituted heteroalkyl] or its pharmaceutically acceptable salt as an active ingredient. COPYRIGHT: (C)2004,JPO
申请公布号 JP2004059454(A) 申请公布日期 2004.02.26
申请号 JP20020217037 申请日期 2002.07.25
申请人 JAPAN ENERGY CORP 发明人 TOBE MASANORI;ISOBE YOSHIAKI;TOMIZAWA HIDEYUKI
分类号 C07D239/94;A61K31/517;A61P1/04;A61P1/16;A61P3/10;A61P7/00;A61P9/10;A61P11/00;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P19/08;A61P21/04;A61P25/00;A61P27/02;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P43/00;C07D401/12;(IPC1-7):C07D239/94 主分类号 C07D239/94
代理机构 代理人
主权项
地址
您可能感兴趣的专利